NASDAQ:VIRI
Delisted

Virios Therapeutics Stock Signals

etoro logo Buy VIRI
*Your capital is at risk
$0.155
+0 (+0%)
At Close: Jan 07, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Virios Therapeutics, LLC

General

Signal Type Signal Value Data
Score 0.000 61 days ( 0 %
Last Price $0.155 0 %
Performance History
7 Days
$0.155 $0.155
0%
30 Days
$0.155 $0.155
0%
12 Mos
$0.588 $0.155
-73.63%

9/18

Active Buy Signals

Specific Signals

Short Term
Net score: 69.59
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.155 - $0.155
Trend - 3 mos 0 % High Width: 0.00000000000007 %
Pred. range - 3 mos $0.155 - $0.155 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 06, 2025 - 2 days
RSI Short Pivot Signal Buy Very Low Oct 24, 2024 - 51 days
Short MA 3 mos Buy Low Oct 10, 2024 - 61 days
Long MA 3 mos Buy Medium Nov 19, 2024 - 33 days
Short/Long MA 3 mos Buy Medium Nov 19, 2024 - 33 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 45.67
Signal Type Signal Value Importance Data
Trend - 12 mos -48.41 % Very High Width: 674.48 %
Pred. range - 12 mos N/A - $0.226 High -100.00 % - 45.66 %
Short MA 12 mos Buy Very High Oct 30, 2024 - 47 days
Long MA 12 mos Buy Very High Apr 11, 2024 - 187 days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Sell Low Jan 06, 2025 - 2 days
RSI Long Pivot Signal Buy Low Nov 04, 2024 - 44 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT VIRIOS THERAPEUTICS, LLC
Virios Therapeutics
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, atten...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE